Other Events ·
The Court of Milan issued an interim order regarding a legal challenge by minority shareholders
GNTAGenenta Science S.p.A.
The Court of Milan issued an interim order regarding a legal challenge by minority shareholders. The Court denied a request to suspend the May 2, 2024, multiple voting rights mechanism, leaving it in effect. However, the Court suspended the efficacy of the October 29, 2025, resolution amending the Company's corporate purpose due to concerns regarding its breadth. Genenta Science S.p.A. is a biotechnology company focused on developing advanced therapeutic solutions.